{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T01:40:30Z","timestamp":1771897230275,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":1957,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1074\/jbc.m114.626960","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T02:22:33Z","timestamp":1427163753000},"page":"12558-12571","source":"Crossref","is-referenced-by-count":40,"title":["Induction of Heme Oxygenase-1 by Na+-H+ Exchanger 1 Protein Plays a Crucial Role in Imatinib-resistant Chronic Myeloid Leukemia Cells"],"prefix":"10.1016","volume":"290","author":[{"given":"Dan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tangsheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jishi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M114.626960_bib1","first-page":"596483","article-title":"Therapy of chronic myeloid leukemia: twilight of the imatinib era?","volume":"2014","author":"Trela","year":"2014","journal-title":"ISRN Oncol"},{"key":"10.1074\/jbc.M114.626960_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5581\/1516-8484.20140014","article-title":"Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia","volume":"36","author":"de Almeida","year":"2014","journal-title":"Rev. Bras. Hematol. Hemoter"},{"key":"10.1074\/jbc.M114.626960_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2014.01.033","article-title":"Discontinuation of tyrosine kinase inhibitors and new approaches to target leukemic stem cells: treatment-free remission as a new goal in chronic myeloid leukemia","volume":"347","author":"Breccia","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1074\/jbc.M114.626960_bib4","doi-asserted-by":"crossref","first-page":"e2014007","DOI":"10.4084\/mjhid.2014.007","article-title":"Imatinib in chronic myeloid leukemia: an overview","volume":"6","author":"Sacha","year":"2014","journal-title":"Mediterr. J. Hematol. Infect. Dis"},{"key":"10.1074\/jbc.M114.626960_bib5","doi-asserted-by":"crossref","first-page":"e2014005","DOI":"10.4084\/mjhid.2014.005","article-title":"Treatment recommendations for chronic myeloid leukemia","volume":"6","author":"Baccarani","year":"2014","journal-title":"Mediterr. J. Hematol. Infect. Dis"},{"key":"10.1074\/jbc.M114.626960_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.2013.52.9230","article-title":"Patient with chronic myeloid leukemia in complete cytogenetic response: what does it mean, and what does one do next?","volume":"32","author":"Marin","year":"2014","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.M114.626960_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000353163","article-title":"Identifying the time to change BCR-ABL inhibitor therapy in patients with chronic myeloid leukemia","volume":"130","author":"Savona","year":"2013","journal-title":"Acta Haematol"},{"key":"10.1074\/jbc.M114.626960_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.clml.2013.03.018","article-title":"Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: a clinical perspective and emerging treatment options","volume":"13","author":"Jabbour","year":"2013","journal-title":"Clin. Lymphoma Myeloma Leuk"},{"key":"10.1074\/jbc.M114.626960_bib9","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood.V99.9.3472","article-title":"High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR\/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance","volume":"99","author":"Branford","year":"2002","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.626960_bib10","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1039\/c3mb70577c","article-title":"In silico identification of novel kinase inhibitors targeting wild-type and T315I mutant ABL1 from FDA-approved drugs","volume":"10","author":"Xu","year":"2014","journal-title":"Mol. Biosyst"},{"key":"10.1074\/jbc.M114.626960_bib11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2011-08-358135","article-title":"Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience","volume":"119","author":"Kantarjian","year":"2012","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.626960_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12185-012-1093-y","article-title":"Comprehensive therapeutic outcomes of frontline imatinib mesylate in newly diagnosed chronic phase chronic myeloid leukemia patients in Korea: feasibility assessment of current ELN recommendation","volume":"96","author":"Kim","year":"2012","journal-title":"Int. J. Hematol"},{"key":"10.1074\/jbc.M114.626960_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12185-014-1531-0","article-title":"Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status","volume":"99","author":"Kawajiri","year":"2014","journal-title":"Int. J. Hematol"},{"key":"10.1074\/jbc.M114.626960_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M114.626960_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science"},{"key":"10.1074\/jbc.M114.626960_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canlet.2014.03.012","article-title":"HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia","volume":"348","author":"Yun","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1074\/jbc.M114.626960_bib17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.leukres.2013.12.025","article-title":"BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome","volume":"38","author":"Elias","year":"2014","journal-title":"Leuk. Res"},{"key":"10.1074\/jbc.M114.626960_bib18","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood-2006-11-055723","article-title":"Targeting of heat shock protein 32 (Hsp32)\/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib","volume":"111","author":"Mayerhofer","year":"2008","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.626960_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-4165(02)00303-3","article-title":"A rapid method for measuring intracellular pH using BCECF-AM","volume":"1572","author":"Ozkan","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M114.626960_bib20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCRESAHA.108.175877","article-title":"Protein kinase B\/Akt phosphorylates and inhibits the cardiac Na+\/H+ exchanger NHE1","volume":"103","author":"Snabaitis","year":"2008","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M114.626960_bib21","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/jcb.23090","article-title":"Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells","volume":"112","author":"Ruvolo","year":"2011","journal-title":"J. Cell. Biochem"},{"key":"10.1074\/jbc.M114.626960_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2012.12.003","article-title":"Protein kinase c-\u03b2-dependent activation of NF-\u03baB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo","volume":"23","author":"Lutzny","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M114.626960_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2310\/JIM.0b013e318237eb55","article-title":"Protein kinase C-\u03b2 inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma cells","volume":"60","author":"Saba","year":"2012","journal-title":"J. Investig. Med"},{"key":"10.1074\/jbc.M114.626960_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/ars.2005.7.385","article-title":"Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation","volume":"7","author":"Kobayashi","year":"2005","journal-title":"Antioxid. Redox. Signal"},{"key":"10.1074\/jbc.M114.626960_bib25","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1161\/CIRCULATIONAHA.109.905471","article-title":"Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart","volume":"121","author":"Wang","year":"2010","journal-title":"Circulation"},{"key":"10.1074\/jbc.M114.626960_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000086044","article-title":"Cytoprotective effects of heme oxygenase in acute renal failure","volume":"148","author":"Akagi","year":"2005","journal-title":"Contrib. Nephrol"},{"key":"10.1074\/jbc.M114.626960_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3892\/or.2010.1125","article-title":"Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder","volume":"25","author":"Miyake","year":"2011","journal-title":"Oncol. Rep"},{"key":"10.1074\/jbc.M114.626960_bib28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/ijc.23695","article-title":"Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice","volume":"123","author":"Sass","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M114.626960_bib29","doi-asserted-by":"crossref","first-page":"11657","DOI":"10.1073\/pnas.94.21.11657","article-title":"Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons","volume":"94","author":"Du","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.626960_bib30","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/ijms15011625","article-title":"Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy","volume":"15","author":"Lin","year":"2014","journal-title":"Int. J. Mol. Sci"},{"key":"10.1074\/jbc.M114.626960_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0898-6568(03)00101-3","article-title":"Bcr-Abl-mediated molecular mechanism for apoptotic suppression in multipotent haemopoietic cells: a role for PKC\u03b2II","volume":"16","author":"Xenaki","year":"2004","journal-title":"Cell. Signal"},{"key":"10.1074\/jbc.M114.626960_bib32","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1158\/0008-5472.CAN-13-1075","article-title":"Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth","volume":"73","author":"Wegiel","year":"2013","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M114.626960_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000356649","article-title":"Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus b3-induced myocarditis","volume":"33","author":"Ursu","year":"2014","journal-title":"Cell Physiol. Biochem"},{"key":"10.1074\/jbc.M114.626960_bib34","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.2174\/1381612811319150012","article-title":"Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells","volume":"19","author":"Tibullo","year":"2013","journal-title":"Curr. Pharm. Des"},{"key":"10.1074\/jbc.M114.626960_bib35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cellsig.2013.12.011","article-title":"Protein kinase C-\u03b2 mediates neuronal activation of Na+\/H+ exchanger-1 during glutamate excitotoxicity","volume":"26","author":"Lee","year":"2014","journal-title":"Cell. Signal"},{"key":"10.1074\/jbc.M114.626960_bib36","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1158\/1535-7163.MCT-07-0148","article-title":"Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein","volume":"6","author":"Katayama","year":"2007","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.M114.626960_bib37","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/sj.onc.1203467","article-title":"The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6\/Abl) have altered substrate preferences and activate similar intracellular signalling pathways","volume":"19","author":"Voss","year":"2000","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.626960_bib38","doi-asserted-by":"crossref","first-page":"17581","DOI":"10.1074\/jbc.M702206200","article-title":"PO2-dependent differential regulation of multidrug resistance 1 gene expression by the c-Jun NH2-terminal kinase pathway","volume":"282","author":"Liu","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.626960_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1158\/0008-5472.CAN-05-1779","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase","volume":"66","author":"Zhou","year":"2006","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M114.626960_bib40","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00125-013-3053-3","article-title":"PREP1 deficiency downregulates hepatic lipogenesis and attenuates steatohepatitis in mice","volume":"56","author":"Oriente","year":"2013","journal-title":"Diabetologia"},{"key":"10.1074\/jbc.M114.626960_bib41","doi-asserted-by":"crossref","first-page":"44675","DOI":"10.1074\/jbc.M307633200","volume":"278","author":"Bloom","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.626960_bib42","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.febslet.2008.06.045","article-title":"The coffee diterpene kahweol induces heme oxygenase-1 via the PI3K and p38\/Nrf2 pathway to protect human dopaminergic neurons from 6-hydroxydopamine-derived oxidative stress","volume":"582","author":"Hwang","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.M114.626960_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tox.2007.10.011","article-title":"Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice","volume":"243","author":"Randle","year":"2008","journal-title":"Toxicology"},{"key":"10.1074\/jbc.M114.626960_bib44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.phrs.2008.09.003","article-title":"Dual roles of Nrf2 in cancer","volume":"58","author":"Lau","year":"2008","journal-title":"Pharmacol. Res"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820337297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820337297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M114.626960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T06:26:02Z","timestamp":1620282362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820337297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":44,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0021925820337297"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m114.626960","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}